Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Zachary Sethna

Showing results (11-20 of 13) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 13 results.
Nature|May 11, 2022
Fundamental immune-oncogenicity trade-offs define driver mutation fitnessDavid Hoyos, Roberta Zappasodi, Isabell Schulze, et al.
Nature|February 19, 2025
RNA neoantigen vaccines prime long-lived CD8<sup>+</sup> T cells in pancreatic cancerZachary Sethna, Pablo Guasp, Charlotte Reiche, et al.
Nature|May 10, 2023
Personalized RNA neoantigen vaccines stimulate T cells in pancreatic cancerLuis A Rojas, Zachary Sethna, Kevin C Soares, et al.
Pageof 2

Showing results (11-20 of 13) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 13 results.
Nature|May 11, 2022
Fundamental immune-oncogenicity trade-offs define driver mutation fitnessDavid Hoyos, Roberta Zappasodi, Isabell Schulze, et al.
Nature|February 19, 2025
RNA neoantigen vaccines prime long-lived CD8<sup>+</sup> T cells in pancreatic cancerZachary Sethna, Pablo Guasp, Charlotte Reiche, et al.
Nature|May 10, 2023
Personalized RNA neoantigen vaccines stimulate T cells in pancreatic cancerLuis A Rojas, Zachary Sethna, Kevin C Soares, et al.
Pageof 2